দেশ: আয়ার্লণ্ড
ভাষা: ইংরেজি
সূত্র: HPRA (Health Products Regulatory Authority)
Phenobarbital
CP-Pharma Handelsgesellschaft mbH
QN03AA02
Phenobarbital
60 mg/tablet
Tablet
POM: Prescription Only Medicine as defined in relevant national legislation
phenobarbital
Authorised
2020-09-11
Health Products Regulatory Authority 11 September 2020 CRN0093S9 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Phenotab Flavoured 60 mg Tablets for dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE Phenobarbital 60 mg EXCIPIENTS: For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. White, speckled with brown spots, round and convex tablet with a cross-shaped break line on one side. Tablets can be divided into 2 or 4 equal parts. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Prevention of seizures due to generalised epilepsy. 4.3 CONTRAINDICATIONS Do not use in known cases of hypersensitivity to the active substance, any of the excipients or other barbiturates. Do not use in animals with severe liver disease. Do not use in animals with serious renal or cardiovascular disorders. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES It is recommended that the clinical pathology of the patient is monitored, the first time 2-3 weeks after initiation of therapy and subsequently every 4-6 months. It is important to know that the effects of hypoxia can cause increased levels of hepatic enzymes after a seizure. Long-term therapy with phenobarbital results in habituation and dependence, which can lead to a spontaneous return of symptoms upon sudden discontinuation of therapy. To achieve successful therapy, administration of tablets at the same time each day is essential. Some of the dogs are free of epileptic seizures during the treatment, but some of the dogs show only a seizure reduction, and some of the dogs are considered to be non-responders. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Caution is required in animals with impaired liver and / or renal function, hypovolaemia, anemia and cardiac or respiratory dysfunction. Health Products Regulatory Authority 11 Sept সম্পূর্ণ নথি পড়ুন